SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-027304
Filing Date
2024-03-06
Accepted
2024-03-06 17:06:15
Documents
1
Period of Report
2024-03-05

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 6611
  Complete submission text file 0000950170-24-027304.txt   7998
Mailing Address 738 MAIN STREET UNIT 398 WALTHAM MA 02451
Business Address 738 MAIN STREET UNIT 398 WALTHAM MA 02451 617-995-0900
AILERON THERAPEUTICS INC (Issuer) CIK: 0001420565 (see all company filings)

IRS No.: 134196017 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746
Business Address
WINDSOR JAMES BRIAN (Reporting) CIK: 0001790933 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38130 | Film No.: 24726898